Wall Street is finally warming to Palantir after a blowout Q4 that delivered 70% revenue growth, 57% adjusted operating margins, and multiple analyst upgrades, but the stock still suffers from ...
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 28, 2026 / Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ ...
Unlike traditional testing, which requires hundreds or thousands of charge – discharge cycles, the model can estimate a new ...
Public health recommendations suggest individuals can resume normal activities 5 days after symptom cessation. However, our study finds that full recovery can take longer, indicating that delayed ...
Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results